Development of Non-Coding RNAs for Cancer Therapy

4th Annual M. D. Anderson/Baylor College of Medicine Symposium

“Development of Non-Coding RNAs for Cancer Therapy”

Time: 8 a.m. to 5:15 p.m. – program
5:15 p.m. to 6:15 p.m. – reception
Where: Onstead Auditorium & Foyer, BSRB 3.8012
George and Cynthia Mitchell Basic Science Research Building
The University of Texas M. D. Anderson Cancer Center

Official Symposium Program (pdf)

As the appreciation for the importance of non-coding RNAs (ncRNAs) continues to emerge, it is increasingly clear that ncRNAs may play critical roles in gene regulatory processes during development and differentiation. New RNA-based cancer therapies and other discoveries may be exploited for the development of useful biomarkers for cancer diagnosis and prognosis.

The goals of this workshop are to provide an opportunity for clinicians to interact with biologists and bioinformaticians and tackle many of the critical problems of non-coding RNA research and understand better the molecular mechanisms of ncRNAs (and miRNAs) in normal development in biology and in cancer.

George A. Calin, M.D., Ph.D.
Associate Professor
Department of Experimental Therapeutics
M. D. Anderson Cancer Center
Jeffrey M. Rosen, Ph.D.
C.C. Bell Professor
Department of Molecular & Cellular Biology
Baylor College of Medicine

M. D. Anderson logoBaylor College of Medicine/Duncan Cancer Center lolo

Subscribe to the miRNA blog

Thank you for subscribing.

Something went wrong.

Related Posts

Add Comment